Researchers believe that it could be especially beneficial in patients with impaired kidney function who may be at risk of adverse reactions to standard ICM.

The technique has proven effective in adults, but until recently there has been a lack of data on its use among children.

The Symphony Thrombectomy System eliminates tradeoffs between two priorities—leveraging large-bore power and ease of use vs. efficiently reducing clot burden and delivering improved speed. 

In patients with treatment-resistant hypertension, the procedure has the potential to produce sustained blood pressure reductions for 36 months or longer. 

The procedure reduces inflammation and pain, and allows patients to achieve relief without having to undergo surgery and months of physical therapy during recovery. 

Instylla's Embrace Hydrogel Embolic System minimizes bleeding risks during the embolization of hypervascular tumors in the peripheral arteries.

Ablation therapy used to treat hepatocellular carcinoma requires image guidance, which is usually done via ultrasound, CT or MRI.